407
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , ORCID Icon, , , , ORCID Icon, , , , , , , ORCID Icon, , , , ORCID Icon, , , ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, , , , , , ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 369-384 | Published online: 22 Mar 2022

References

  • Kent S, Burn E, Dawoud D, et al. Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2020;39:275–285. doi:10.1007/s40273-020-00981-9
  • Forrest CB, McTigue KM, Hernandez AF, et al. PCORnet® 2020: current state, accomplishments, and future directions. J Clin Epidemiol. 2021;129:60–67. doi:10.1016/j.jclinepi.2020.09.036
  • Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574–578.
  • Sena A, Kostka K, Schuemie M, Posada JD, Schuemie M. ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package. 2020. doi:10.5281/zenodo.4033034.
  • WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020; 2021. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefing-on-covid-19—11-march-2020.
  • Johns Hopkins Coronavirus Resource Center. COVID-19 map; 2021. Available from: https://coronavirus.jhu.edu/map.html. Accessed March 4, 2022.
  • COVID-19-related medical research: a meta-research and critical appraisal; 2021. Available from: https://www.docwirenews.com/abstracts/covid-19-related-Medical-research-A-meta-research-and-critical-appraisal/.
  • Teixeira da Silva JA, Tsigaris P, Erfanmanesh M. Publishing volumes in major databases related to Covid-19. Scientometrics. 2020;1–12. doi:10.1007/s11192-020-03675-3
  • Burn E, You SC, Sena AG, et al. Deep phenotyping of 34,128 adult patients hospitalized with COVID-19 in an international network study. Nat Commun. 2020;11:5009. doi:10.1038/s41467-020-18849-z
  • Subbian V, Solomonides A, Clarkson M, et al. Ethics and Informatics in the age of COVID-19: challenges and recommendations for public health organization and public policy. J Am Med Inform Assoc. 2020;27. doi:10.1093/jamia/ocaa188
  • Madhavan S, Bastarache L, Brown JS, et al. Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers. J Am Med Inform Assoc. 2020. doi:10.1093/jamia/ocaa287
  • Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi:10.1038/s41586-020-2521-4
  • Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54–60. doi:10.1136/amiajnl-2011-000376
  • Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31:4401–4415. doi:10.1002/sim.5620
  • Reisinger SJ, Ryan PB, O’Hara DJ, et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010;17:652–662. doi:10.1136/jamia.2009.002477
  • Kahn MG, Callahan TJ, Barnard J, et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC). 2016;4:1244. doi:10.13063/2327-9214.1244
  • Observational health data sciences, informatics. Chapter 15 data quality; 2021. Available from: https://ohdsi.github.io/TheBookOfOhdsi/DataQuality.html#data-quality-in-general. Accessed March 4, 2022.
  • Schuemie MJ, Cepeda MS, Suchard MA, et al. How confident are we about observational findings in healthcare: a benchmark study. Harv Data Sci Rev. 2020;2. doi:10.1162/99608f92.147cc28e
  • Kadri SS, Gundrum J, Warner S, et al. Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations. JAMA. 2020;324:2553–2554. doi:10.1001/jama.2020.20323
  • HADES. Observational health data sciences and informatics; 2021. Available from: https://ohdsi.github.io/Hades/index.html. Accessed March 4, 2022.
  • Prats-Uribe A, Sena AG, Lai LYH, et al. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021;373:n1038. doi:10.1136/bmj.n1038
  • Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021; 373 :n1435. doi:10.1136/bmj.n1435
  • Haendel M, Chute C, Gersing K. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2020. doi:10.1093/jamia/ocaa196
  • Weber GM, Hong C, Palmer NP, et al.; 4CE Collaborative. International comparisons of harmonized laboratory value trajectories to predict severe COVID-19: leveraging the 4CE collaborative across 342 hospitals and 6 countries: a retrospective cohort study. bioRxiv medRxiv. 2020. doi:10.1101/2020.12.16.20247684
  • Duarte-Salles T, Vizcaya D, Pistillo A, et al. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. Pediatrics September. 2021; 148 (3): e2020042929. doi:10.1542/peds.2020-042929
  • Lai LYH, Golozar A, Sena A, et al. Clinical characteristics, symptoms, management and health outcomes in 8598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis. medRxiv. 2020. doi:10.1101/2020.10.29.20222083
  • Roel E, Pistillo A, Recalde M, et al. Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 1 October 2021; 30 (10): 1884–1894.
  • Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021;60:SI37–SI50. doi:10.1093/rheumatology/keab250